Sun Xiwei, Chen Hang, Liang Shu, Xiao Ticheng, Zeng Yali, Liu Hong, Feng Liao, Zhou Dinglun
West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
Center for AIDS/STD Control and Prevention, Luzhou Center for Disease Control and Prevention, Luzhou, Sichuan, People's Republic of China.
Infect Drug Resist. 2025 Jun 9;18:2943-2950. doi: 10.2147/IDR.S505706. eCollection 2025.
Antiretroviral therapy (ART) has been shown to reduce the number of local HIV (Human Immunodeficiency Virus) reported cases; however, there is insufficient research on the relationship between new HIV infections and ART. This study utilized real-world data to evaluate the community-level effectiveness of ART in reducing new HIV infections.
Ecological study was designed to establish the relationship between ART quality and new HIV infections. New HIV infections were identified through an expanded testing system in 2018-2023; ART quality was evaluated based on ART-treated clients in 2016-2023, and non-probabilistic sampling was performed. Generalized linear models was employed to assess associations between metrics of ART effectiveness and new HIV infections. Statistical significance was set at = 0.05 with 95% confidence intervals.
A total of 3836 new HIV infections were identified, yielding an overall incidence of 2.1%. Treatment coverage for the entire population was 80.8%, and the proportion of clients with an increased CD4 count was 61.0% of the entire population. In the generalized linear modeling, four key factors were associated with reduced new HIV infections: a greater number of clients undergoing treatment, a higher proportion of clients demonstrated CD4 count improvement, higher level of CD4 in baseline, and a reduction in reported cases ( = -0.04, -0.03, -0.01, 0.17 respectively).
This ecological study verified that expanding treatment coverage, optimizing the effectiveness of antiretroviral treatment and elevating baseline CD4 counts could curb community-level new HIV infections. Early detection, prompt treatment, and effective ART are crucial for curbing HIV transmission in regions mainly driven by sexual transmission and with high cumulative incidence rates.
抗逆转录病毒疗法(ART)已被证明可减少当地报告的人类免疫缺陷病毒(HIV)病例数量;然而,关于新的HIV感染与ART之间的关系,研究尚不充分。本研究利用真实世界数据评估ART在社区层面减少新HIV感染的效果。
设计生态研究以确定ART质量与新HIV感染之间的关系。通过2018 - 2023年扩大检测系统识别新的HIV感染;基于2016 - 2023年接受ART治疗的患者评估ART质量,并进行非概率抽样。采用广义线性模型评估ART有效性指标与新HIV感染之间的关联。设定统计学显著性为α = 0.05,置信区间为95%。
共识别出3836例新的HIV感染,总体发病率为2.1%。整个人口的治疗覆盖率为80.8%,CD4细胞计数增加的患者比例占整个人口的61.0%。在广义线性模型中,有四个关键因素与新HIV感染减少相关:接受治疗的患者数量增加、CD4细胞计数改善的患者比例更高、基线CD4水平更高以及报告病例减少(分别为β = -0.04、-0.03、-0.01、0.17)。
这项生态研究证实,扩大治疗覆盖率、优化抗逆转录病毒治疗效果以及提高基线CD4细胞计数可遏制社区层面新的HIV感染。早期检测、及时治疗和有效的ART对于在主要由性传播驱动且累积发病率高的地区遏制HIV传播至关重要。